Doctor-patient communication

In the oncology clinic: how to talk after another treatment setback

On this page

TL;DR: For a doctor in an oncology clinic, further disease progression is a continuation of an ongoing conversation, not a single piece of bad news. It helps to check what the patient previously understood, explain why the plan is changing, ask again about their priorities, and agree when to revisit unresolved questions.

How can Empatyzer help with a conversation after a cancer treatment setback?

“About Me” helps the doctor notice an impulse to offer reassurance too quickly, while Em helps them prepare a new explanation of the plan.

Features that can help:

  • Talk with Em about yourself: With Em, the doctor practises opening with earlier decisions, explaining the next step, and asking about the patient’s priorities.
  • Micro-lessons: “About Me” helps the doctor reflect on their response to the patient’s sadness, while micro-lessons support a thoughtful summary of the conversation.
  • About Me: “About Me” helps the doctor recognize their own impulse to offer reassurance too quickly.

The news has a history

Another result showing that treatment has not worked does not reach the patient in isolation. It follows earlier conversations, hopes attached to treatment, and expectations about what would happen next. The doctor can therefore begin by asking how the patient understood the previous result and the plan agreed at the time. It is also worth checking what they remember from that conversation rather than assuming both sides are starting from the same understanding today. A synthesis of 28 qualitative studies covering the experiences of 976 people with cancer helps show why their perspectives matter when difficult news is shared. It does not, however, establish a single, inevitable sequence of emotions. The starting point for each person is their own history of illness and previous conversations.

What has changed today

After revisiting earlier decisions, the doctor needs to state clearly what has changed their assessment today. Is it a specific result, a limit to the available treatment options, or a change in the goal of treatment? Making this distinction helps the patient connect the new information with the plan they knew until now. The doctor should separate the evidence already available from the prognosis and explain which decisions can be made now and which require more information. It is not enough to name the result and move straight to the next treatment. The patient also needs time to ask what the change means for daily life: symptoms, plans, and the things that matter to them. What remains uncertain at this stage should be stated just as clearly.

Different needs at different stages

A patient’s preferences for information may change with each new result, as the disease progresses and the plan changes. Someone who previously wanted every detail may need a shorter explanation today; another person may only now want to discuss the options and goals of care in depth. It is therefore worth asking again how much information the patient wants in this conversation rather than carrying over an answer from the previous visit. A synthesis of patients’ experiences describes varied needs when receiving difficult news, while a synthesis of oncologists’ experiences sheds light on the challenges of delivering such news repeatedly. These are accounts of experience, not evidence of a universal sequence of reactions. Asking the patient now helps tailor the conversation to where they are today.

Uncertainty without empty promises

Uncertainty calls for neither silence nor a promise of improvement that the available evidence cannot support. The doctor can explain what the result already shows, what decision can be made today, and which question cannot be answered until another test. The limits of the prognosis should also be made clear: an honest account of what cannot yet be predicted. The doctor and patient can then agree when the plan will be updated and when they will speak again. This approach leaves room for hope without presenting any treatment outcome as certain. For one patient, hope may lie in an available treatment; for another, in time with loved ones or better symptom control. The best way to find out what hope means to the patient is to ask.

The family’s role

Loved ones can help a patient remember information and frame questions, but their involvement should first be agreed with the patient. The doctor can ask whom the patient would like to invite into the conversation and whether they would prefer to hear the explanation alone first. If family members attend, it helps to give the patient a chance to ask the first question before others begin speaking for them. What loved ones want may differ from what the patient wants to know or focus on. Their wishes should not automatically replace the patient’s voice. Consistency across the care team also matters: conflicting explanations make the next plan harder to understand. After the conversation, it is worth making sure the patient knows whom they can contact with questions.

The burden on the treating doctor

Repeated conversations about treatments that have not worked also take a toll on doctors. They require time and a suitable setting, not just carefully chosen words. Before the visit, it helps to establish who on the team will be available if the patient has further questions afterward. That commitment to the patient is distinct from the doctor’s need to briefly consult the team after a difficult conversation. Both matter, but they serve different purposes. A synthesis of 40 qualitative studies describes oncologists’ experiences of communicating difficult news. It does not show that one script or way of phrasing things works better than others. Preparation should therefore cover the setting and follow-up as well as the words used.

Returning to the plan

The end of the visit is a time to return to the plan, but it should not become a rushed list of instructions. The doctor can summarize the available options, explain what will happen now, and say who will contact the patient and when. It also helps to identify unresolved questions separately and agree when both sides will return to them. Because the plan may have changed many times during treatment, the doctor should ask how the patient understands the current change and the next step. Silence after an explanation does not mean the news has been understood or accepted. Checking understanding is not a test of the patient; it gives the doctor a chance to clarify their own explanation. That way, the next contact follows naturally from the conversation rather than remaining a vague promise.

A conversation about disease progression does not start from scratch. The doctor revisits earlier decisions, checks the patient’s current needs, and ends the visit with a clear plan for follow-up.

Empatyzer in conversations after a cancer treatment setback

Before a visit following another treatment setback, a doctor can use Empatyzer to prepare for the conversation, not to replace it with a ready-made script. A conversation with Em offers a chance to practise opening with earlier decisions, explaining the next step simply, and asking about the patient’s current priorities. Em can also help prepare two versions of an explanation for the change in plan: one shorter and one more detailed, depending on how much the patient wants to hear today. In the “About Me” section, the doctor can reflect on their own response to the patient’s sadness, particularly an impulse to offer reassurance too quickly that might drown out an important question. Micro-lessons support asking again about information needs at each stage and summarizing the visit with care. The aim of this preparation is to speak honestly about the change in plan, make room for the patient’s own goals, and agree clearly on what will happen after the conversation.

Sources

  1. Primeau, C., Chau, M., Turner, M. R., Paterson, C. (2024). Patient Experiences of Patient–Clinician Communication Among Cancer Multidisciplinary Healthcare Professionals During “Breaking Bad News”: A Qualitative Systematic Review. Seminars in Oncology Nursing, 40(4), 151680. https://doi.org/10.1016/j.soncn.2024.151680 10.1016/j.soncn.2024.151680
  2. Bousquet, G., Orri, M., Winterman, S., Brugière, C., Verneuil, L., & Revah-Levy, A. (2015). Breaking Bad News in Oncology: A Metasynthesis. Journal of Clinical Oncology, 33(22), 2437–2443. https://doi.org/10.1200/JCO.2014.59.6759 10.1200/JCO.2014.59.6759